These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26228173)

  • 1. [Autoimmune skin diseases].
    Beissert S; Hertl M
    Hautarzt; 2015 Aug; 66(8):572-3. PubMed ID: 26228173
    [No Abstract]   [Full Text] [Related]  

  • 2. [The skin, an interdisciplinary organ].
    Itin PH; Hengge UR; Battegay M
    Internist (Berl); 2009 Feb; 50(2):135-6. PubMed ID: 19212723
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoimmune skin diseases in the dog.
    Parker WM
    Can Vet J; 1981 Oct; 22(10):302-4. PubMed ID: 7044514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Targeted therapy: old and new possibilities].
    Hochhaus A; Lüftner D; Mackensen A
    Onkologie; 2013; 36 Suppl 5():2-11. PubMed ID: 23921800
    [No Abstract]   [Full Text] [Related]  

  • 5. Approach to the patient with autoimmune mucocutaneous blistering diseases.
    Sami N
    Dermatol Ther; 2011; 24(2):173-86. PubMed ID: 21410607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dermatology -- the most progressive discipline in medicine].
    Röcken M
    J Dtsch Dermatol Ges; 2015 Jul; 13(7):617-9. PubMed ID: 26110720
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy of autoimmune diseases.
    Bach JF
    Recenti Prog Med; 1988; 79(7-8):343-50. PubMed ID: 3059421
    [No Abstract]   [Full Text] [Related]  

  • 8. [What's new in internal medicine?].
    Laffitte E
    Ann Dermatol Venereol; 2014 Dec; 141 Suppl 4():S616-21. PubMed ID: 25539753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Practical management of the most common autoimmune bullous diseases].
    Suárez-Fernández R; España-Alonso A; Herrero-González JE; Mascaró-Galy JM
    Actas Dermosifiliogr; 2008; 99(6):441-55. PubMed ID: 18558052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologics in the treatment of skin and rheumatologic diseases.
    Kahlenberg JM; Billi AC; Eyerich K; Gudjonsson JE
    J Allergy Clin Immunol; 2020 Apr; 145(4):1138-1141. PubMed ID: 32112793
    [No Abstract]   [Full Text] [Related]  

  • 11. [Trends in the treatment of immunologic system diseases].
    Tonietti G; Passacantando A
    Recenti Prog Med; 1999 Nov; 90(11):575-8. PubMed ID: 10608145
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lupus therapy on the move : The direction is right!].
    Fischer-Betz R; Aringer M
    Z Rheumatol; 2015 Apr; 74(3):182. PubMed ID: 25854150
    [No Abstract]   [Full Text] [Related]  

  • 13. Introduction to autoinflammatory syndromes and diseases.
    Abramovits W; Oquendo M
    Dermatol Clin; 2013 Jul; 31(3):363-85. PubMed ID: 23827242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease.
    Khosroshahi A; Wallace ZS; Crowe JL; Akamizu T; Azumi A; Carruthers MN; Chari ST; Della-Torre E; Frulloni L; Goto H; Hart PA; Kamisawa T; Kawa S; Kawano M; Kim MH; Kodama Y; Kubota K; Lerch MM; Löhr M; Masaki Y; Matsui S; Mimori T; Nakamura S; Nakazawa T; Ohara H; Okazaki K; Ryu JH; Saeki T; Schleinitz N; Shimatsu A; Shimosegawa T; Takahashi H; Takahira M; Tanaka A; Topazian M; Umehara H; Webster GJ; Witzig TE; Yamamoto M; Zhang W; Chiba T; Stone JH;
    Arthritis Rheumatol; 2015 Jul; 67(7):1688-99. PubMed ID: 25809420
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of monoclonal antibodies to achieve immunological tolerance.
    Waldmann H; Cobbold S
    Immunol Today; 1993 Jun; 14(6):247-51. PubMed ID: 8397765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive therapy of autoimmune diseases.
    Bach JF
    Immunol Today; 1993 Jun; 14(6):322-6. PubMed ID: 8104411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement.
    Ross AH; Jaycock P; Cook SD; Dick AD; Tole DM
    Br J Ophthalmol; 2009 Apr; 93(4):421-2, 548. PubMed ID: 19321473
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of immune-mediated skin diseases: future perspectives.
    Luger T
    Eur J Dermatol; 2001; 11(4):343-7. PubMed ID: 11399542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibody and antibody-targeted therapy].
    Becker JC
    J Dtsch Dermatol Ges; 2006 Aug; 4(8):703. PubMed ID: 16895576
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
    Daoud YJ; Amin KG
    Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.